Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Photodynamic therapy--new approaches.

T J Dougherty1

  • 1Department of Radiation Medicine, Roswell Park Memorial Institute, Buffalo, New York.

Seminars in Surgical Oncology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targets, targets everywhere--so where are the new antibacterial drugs?

IDrugs : the investigational drugs journal·2005
Same author

American Society of Microbiology - 100th General Meeting.

IDrugs : the investigational drugs journal·2005
Same author

What will genomics bring to the finish line?

IDrugs : the investigational drugs journal·2005
Same author

Why are there no new antibiotics?

Expert opinion on investigational drugs·2005
Same author

98th General Meeting of the American Society for Microbiology. May 17-21, 1998; Atlanta, GA.

Expert opinion on investigational drugs·2005
Same author

Pharmacogenomics--is there a role in antibiotic therapy?

The pharmacogenomics journal·2002

Photodynamic therapy (PDT) uses photosensitizers and light to eradicate tissue. Advances in technology and new photosensitizers are expanding PDT

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) is a treatment modality requiring a photosensitizer, light activation, and targeted tissue eradication.
  • While clinical results have been available for years, recent technological advancements have enabled Phase III clinical trials.

Purpose of the Study:

  • To review the current status and future prospects of photodynamic therapy (PDT).
  • To highlight the role of photosensitizers and light delivery systems in PDT efficacy.

Main Methods:

  • Review of clinical trial data and technological developments in PDT.
  • Focus on Photofrin II, a photosensitizer used in Phase III trials for bladder and lung cancers.
  • Discussion of emerging photosensitizers and light delivery systems.

Related Experiment Videos

Main Results:

  • Photofrin II is effective for various malignant tumors and is undergoing Phase III trials.
  • New photosensitizers offer potential for increased efficiency and reduced side effects like cutaneous photosensitivity.
  • Advancements in light sources and delivery systems are improving PDT applicability.

Conclusions:

  • Photodynamic therapy (PDT) is a promising treatment modality with increasing clinical acceptance.
  • Ongoing research into novel photosensitizers and improved light delivery systems will further enhance PDT's therapeutic potential.
  • PDT is poised for broader adoption in medical and biological sciences.